ARTICLE SUMMARY:
Emerging cardiovascular companies are staking claims in pulsed field ablation and percutaneous ventricular assist devices. Biogen Digital Health identifies and validates digital biomarkers to accelerate neuroscience drug development; we look at their program to personalize multiple sclerosis care. Also in this issue, part 2 of our feature on Fogarty Innovation and profiles of start-ups Hyfe and Neuro One.
